Treatment of ischemia referfusion injury and treatment of cellular dysfunction including arrhythmia and heart failure subsequent to myocardial infarction using pyridoxal-5'-phosphate, pyridoxine, pyridoxal and pyridoxamine

摘要

Use of pyridoxal-5'-phosphate, pyridoxine, pyridoxal and pyridoxamine in the manufacture of a medicament for the treatment of ischemia referfusion injury and cellular dysfunction including arrhythmia and heart failure subsequent to myocardial infarction